As well as the causal link to multiple sclerosis, EBV is associated with diseases and cancers including Hodgkin's lymphoma and nasopharyngeal cancer. The virus can be life-threatening in immunocompromised patients such as transplant recipients. Lead author Dr Vijayendra Dasari from QIMR Berghofer said it was rewarding to see so many years of research getting to this stage of development. "QIMR Berghofer has been researching the role of EBV in disease and cancer for decades. It is a really proud moment for us to see all of this work coming together, with this vaccine now heading towards the next important stages of development," Dr Dasari said.

https://www.miragenews.com/vaccine-breakthrough-bolsters-fight-against-ebv-1062090/

#miragenews